Royal Bank of Canada’s IN8bio INAB Stock Holding History

Royal Bank of Canada’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7	Closed	–	–	7113
2024 Q2	$0	Buy	7 +5	+250%	+$160	﹤0.01%	7274
2024 Q1	$0	Sell	2 -7	-78%	-$264	﹤0.01%	7266
2023 Q4	$0	Buy	9 +5	+125%	+$160	﹤0.01%	7328
2023 Q3	$0	Sell	4 -5	-56%	-$188	﹤0.01%	7310
2023 Q2	$0	Buy	9 +7	+350%	+$438	﹤0.01%	7429
2023 Q1	$0	Buy	+2	New	+$112	﹤0.01%	7254
2022 Q4	–	Sell	-5	Closed	–	–	7449
2022 Q3	$0	Buy	+5	New	+$336	﹤0.01%	7623

Other funds holding INAB

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Royal Bank of Canada's INAB Position: Q3 2024 in Review

Royal Bank of Canada sold out of IN8bio (INAB) in Q3 2024, closing a stake of 7 shares.

Royal Bank of Canada first reported a position in INAB in Q3 2022 and held it in 7 quarters. The position peaked at $0 in Q2 2024. 26 funds tracked by Wall St. Rank hold INAB as of Q3 2024.

Royal Bank of Canada reported no remaining IN8bio position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 7 IN8bio shares in Q3 2024.
Royal Bank of Canada first reported a position in IN8bio in Q3 2022 and held it in 7 quarters.
Royal Bank of Canada's IN8bio position peaked at $0 in Q2 2024.
26 funds tracked by Wall St. Rank held IN8bio as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.